PBH

Prestige Consumer Healthcare Inc. Common Stock (PBH)

Stock · NYSE · Health Care

$52.47as of 8/28/2026

Active signals

No technical signal is currently active for this symbol.

Support level
$47.02
Industry
Biotechnology: Pharmaceutical Preparations

Prestige Consumer Healthcare Inc. Common Stock Competitors

Chosen by industry and closest market cap.

  • PBH
    Prestige Consumer Healthcare Inc. Common Stock
    $52.47
    ▲ 2.46%
    Market cap $2.46BP/E
  • RARE
    Ultragenyx Pharmaceutical Inc. Common Stock
    $25.62
    ▼ 2.46%
    Market cap $2.46BP/E
    $18.29$39.89
  • NKTR
    Nektar Therapeutics Common Stock
    $72.57
    ▼ 2.66%
    Market cap $2.38BP/E
    $27.87$109
  • TRVI
    Trevi Therapeutics Inc. Common Stock
    $16.78
    ▼ 6.60%
    Market cap $2.54BP/E
    $6.93$20.22
  • PGEN
    Precigen Inc. Common Stock
    $6.94
    ▼ 3.55%
    Market cap $2.36BP/E
    $2.99$7.72
  • VERA
    Vera Therapeutics Inc. Class A Common Stock
    $34.19
    ▼ 1.18%
    Market cap $2.31BP/E
    $21.2$56.05
  • IMNM
    Immunome Inc. Common Stock
    $27.57
    ▼ 4.50%
    Market cap $2.61BP/E
    $8.67$30.06

P/E shows — for peers not currently carrying a live signal of their own.

Institutional Ownership

March 31, 2026

Total shares held
48.28M
Total value held
$2.77B
Institutional holders
342
Top holders this quarter
  • Unknown7.39M
  • Unknown4.27M
  • Unknown2.67M
  • Unknown2.20M
  • Unknown2.09M
  • Unknown1.97M
  • Unknown1.56M
  • Unknown1.46M
  • Unknown1.36M
  • Unknown1.12M

See the full, filterable feed with live charts on the MarketWall dashboard.

We use analytics to understand how market-wall is used. No personal data is sold.